Variable GLP-1 receptor expression across diverse neuroendocrine neoplasms: implications for incretin therapies
{{output}}
Neuroendocrine neoplasms (NENs) are rare cancers originating in various organs and are further classified as well-differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs). Commonly used drugs such as proton pump in... ...